Literature DB >> 28934437

Group B Streptococcus and the Vaginal Microbiota.

Geoffrey H Rosen1, Tara M Randis2,3,4, Purnahamsi V Desai2,3, Katherine J Sapra2, Bing Ma5,6, Pawel Gajer5,6, Michael S Humphrys6, Jacques Ravel5,6, Shari E Gelber7, Adam J Ratner2,3,4.   

Abstract

Background: Streptococcus agalactiae (group B Streptococcus [GBS]) is an important neonatal pathogen and emerging cause of disease in adults. The major risk factor for neonatal disease is maternal vaginal colonization. However, little is known about the relationship between GBS and vaginal microbiota.
Methods: Vaginal lavage samples from nonpregnant women were tested for GBS, and amplicon-based sequencing targeting the 16S ribosomal RNA V3-V4 region was performed.
Results: Four hundred twenty-eight of 432 samples met the high-quality read threshold. There was no relationship between GBS carriage and demographic characteristics, α-diversity, or overall vaginal microbiota community state type (CST). Within the non-Lactobacillus-dominant CST IV, GBS positive status was significantly more prevalent in CST IV-A than CST IV-B. Significant clustering by GBS status was noted on principal coordinates analysis, and 18 individual taxa were found to be significantly associated with GBS carriage by linear discriminant analysis. After adjusting for race/ethnicity, 4 taxa were positively associated with GBS, and 6 were negatively associated. Conclusions: Vaginal microbiota CST and α-diversity are not related to GBS status. However, specific microbial taxa are associated with colonization of this important human pathogen, highlighting a potential role for the microbiota in promotion or inhibition of GBS colonization.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  group B Streptococcus; neonatal pathogens; vaginal microbiome

Mesh:

Substances:

Year:  2017        PMID: 28934437      PMCID: PMC5853324          DOI: 10.1093/infdis/jix395

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women.

Authors:  Christina Gosmann; Melis N Anahtar; Scott A Handley; Mara Farcasanu; Galeb Abu-Ali; Brittany A Bowman; Nikita Padavattan; Chandni Desai; Lindsay Droit; Amber Moodley; Mary Dong; Yuezhou Chen; Nasreen Ismail; Thumbi Ndung'u; Musie S Ghebremichael; Duane R Wesemann; Caroline Mitchell; Krista L Dong; Curtis Huttenhower; Bruce D Walker; Herbert W Virgin; Douglas S Kwon
Journal:  Immunity       Date:  2017-01-10       Impact factor: 31.745

2.  Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains.

Authors:  Nunzia D'Urzo; Manuele Martinelli; Alfredo Pezzicoli; Virginia De Cesare; Vittoria Pinto; Immaculada Margarit; John Laird Telford; Domenico Maione
Journal:  Appl Environ Microbiol       Date:  2014-01-31       Impact factor: 4.792

3.  Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003).

Authors:  Ben A Lopman; Ruanne Barnabas; Timothy B Hallett; Constance Nyamukapa; Costa Mundandi; Phyllis Mushati; Geoff P Garnett; Simon Gregson
Journal:  Bull World Health Organ       Date:  2006-03-22       Impact factor: 9.408

4.  Mageeibacillus indolicus gen. nov., sp. nov.: a novel bacterium isolated from the female genital tract.

Authors:  Michele N Austin; Lorna K Rabe; Sujatha Srinivasan; David N Fredricks; Harold C Wiesenfeld; Sharon L Hillier
Journal:  Anaerobe       Date:  2014-12-04       Impact factor: 3.331

5.  Temporal and spatial variation of the human microbiota during pregnancy.

Authors:  Daniel B DiGiulio; Benjamin J Callahan; Paul J McMurdie; Elizabeth K Costello; Deirdre J Lyell; Anna Robaczewska; Christine L Sun; Daniela S A Goltsman; Ronald J Wong; Gary Shaw; David K Stevenson; Susan P Holmes; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

6.  Differences in vaginal microbiome in African American women versus women of European ancestry.

Authors:  Jennifer M Fettweis; J Paul Brooks; Myrna G Serrano; Nihar U Sheth; Philippe H Girerd; David J Edwards; Jerome F Strauss; Kimberly K Jefferson; Gregory A Buck
Journal:  Microbiology (Reading)       Date:  2014-07-29       Impact factor: 2.777

7.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

8.  Studies on the pathogenicity of anaerobes, especially Prevotella bivia, in a rat pyometra model.

Authors:  H Mikamo; K Kawazoe; K Izumi; K Watanabe; K Ueno; T Tamaya
Journal:  Infect Dis Obstet Gynecol       Date:  1998

9.  Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.

Authors:  Deirdre E O'Hanlon; Thomas R Moench; Richard A Cone
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Pregnancy's stronghold on the vaginal microbiome.

Authors:  Marina R S Walther-António; Patricio Jeraldo; Margret E Berg Miller; Carl J Yeoman; Karen E Nelson; Brenda A Wilson; Bryan A White; Nicholas Chia; Douglas J Creedon
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more
  22 in total

1.  Gardnerella and Prevotella: Co-conspirators in the Pathogenesis of Bacterial Vaginosis.

Authors:  Tara M Randis; Adam J Ratner
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

2.  Vaginal co-colonization with multiple Group B Streptococcus serotypes.

Authors:  Ameneh Khatami; Tara M Randis; Larissa Tavares; Margaret Gegick; Evan Suzman; Adam J Ratner
Journal:  Vaccine       Date:  2018-12-08       Impact factor: 3.641

Review 3.  Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.

Authors:  Cilicia S do Nascimento; Nayara F B Dos Santos; Rita C C Ferreira; Carla R Taddei
Journal:  Braz J Microbiol       Date:  2019-08-20       Impact factor: 2.476

4.  Probiotic interventions to reduce antepartum Group B streptococcus colonization: A systematic review and meta-analysis.

Authors:  Lisa Hanson; Leona VandeVusse; Emily Malloy; Mauricio Garnier-Villarreal; Lauren Watson; Alissa Fial; Marie Forgie; Katrina Nardini; Nasia Safdar
Journal:  Midwifery       Date:  2021-11-25       Impact factor: 2.640

5.  Deviations in the gut microbiota of neonates affected by maternal group B Streptococcus colonization.

Authors:  Yue-Feng Li; Xue-Lei Gong; Su-Xiang Chen; Kejian Wang; Yan-Hua Jiang
Journal:  BMC Microbiol       Date:  2021-05-05       Impact factor: 3.605

Review 6.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

Review 7.  Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.

Authors:  Julia Kolter; Philipp Henneke
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 8.  Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.

Authors:  Kathryn A Patras; Victor Nizet
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

9.  Gardnerella vaginalis promotes group B Streptococcus vaginal colonization, enabling ascending uteroplacental infection in pregnant mice.

Authors:  Nicole M Gilbert; Lynne R Foster; Bin Cao; Yin Yin; Indira U Mysorekar; Amanda L Lewis
Journal:  Am J Obstet Gynecol       Date:  2020-11-26       Impact factor: 8.661

10.  Potential Application of Bacteriophages in Enrichment Culture for Improved Prenatal Streptococcus agalactiae Screening.

Authors:  Jumpei Uchiyama; Hidehito Matsui; Hironobu Murakami; Shin-Ichiro Kato; Naoki Watanabe; Tadahiro Nasukawa; Keijiro Mizukami; Masaya Ogata; Masahiro Sakaguchi; Shigenobu Matsuzaki; Hideaki Hanaki
Journal:  Viruses       Date:  2018-10-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.